as on February 5, 2026 at 2:29 am IST
Day's Low
Day's High
-1.90%
Downside
11.37%
Upside
52 Week's Low
52 Week's High
0.47%
Downside
895.26%
Upside
Check Acurx Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$6.4M
EPS (TTM)
-5.71
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-291.07%
Compare market cap, revenue, PE, and other key metrics of Acurx Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $6.4M | NA | NA | 0.00% | |
| BUY | $122.3B | 118.58% | 33.56 | 31.35% | |
| BUY | $47.7B | 113.17% | 1246.03 | 1.36% | |
| NA | $37.4B | NA | 662.33 | 1.38% | |
| BUY | $80.8B | 55.33% | 18.28 | 32.13% |
The Acurx Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Acurx Pharmaceuticals Inc investment value today
Current value as on today
₹17,094
Returns
Returns from Acurx Pharmaceuticals Inc Stock
Dollar Returns*
₹3,873 (+3.87%)
Based on 8 analysts
87.50%
Buy
12.50%
Hold
0.00%
Sell
Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Acurx Pharmaceuticals Inc. Average target price of $61.7
Get share price movements and forecasts by analysts on Acurx Pharmaceuticals Inc.
What analysts predicted
96.58%UPSIDE
Target Price
$61.7
Current Price
$2.11
Analyzed by
8 Analysts
Target
$61.70
Acurx Pharmaceuticals Inc target price $61.7, a slight upside of 96.58% compared to current price of $2.11. According to 8 analysts rating.
Search interest for Acurx Pharmaceuticals Inc Stock has decreased by -39% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 54.6% return, outperforming this stock by 141.4%
Against Peers
![]()
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 37.0% return, outperforming this stock by 134.0%
Price Dip
![]()
In the last 7 days, ACXP stock has moved down by -15.8%
| Organisation | Acurx Pharmaceuticals Inc |
| Headquarters | 259 Liberty Avenue, Staten Island, NY, United States, 10305 |
| CEO | Mr. David P. Luci CPA, Esq., J.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Robert J. DeLuccia | Co-Founder & Executive Chairman |
Mr. David P. Luci CPA, Esq., J.D. | Co-Founder, President, CEO, Corporate Secretary & Director |
Mr. Robert G. Shawah CPA | Co-Founder & CFO |
Acurx Pharmaceuticals Inc share price today is $2.11 as on at the close of the market. Acurx Pharmaceuticals Inc share today touched a day high of $2.35 and a low of $2.15.
Acurx Pharmaceuticals Inc share touched a 52 week high of $21 on and a 52 week low of $2.1 on . Acurx Pharmaceuticals Inc stock price today i.e. is closed at $2.11,which is 89.95% down from its 52 week high and 0.48% up from its 52 week low.
Acurx Pharmaceuticals Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Acurx Pharmaceuticals Inc (ACXP) shares with as little as ₹90.453 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹904.53 in Acurx Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Acurx Pharmaceuticals Inc share’s latest price of $2.11 as on February 5, 2026 at 2:29 am IST, you will get 4.7393 shares of Acurx Pharmaceuticals Inc. Learn more about
fractional shares .